[
  {
    "ts": null,
    "headline": "Assembly Biosciences Says First Participant Dosed in Phase 1b Study of HSV Drug ABI-1179",
    "summary": "Assembly Biosciences (ASMB) said Monday the first participant has been dosed in the phase 1b portion",
    "url": "https://finnhub.io/api/news?id=2536659f2a5724962b4cc9da872bb6ce346b308b09ebce3d0618341b3fbeebeb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751296108,
      "headline": "Assembly Biosciences Says First Participant Dosed in Phase 1b Study of HSV Drug ABI-1179",
      "id": 135664552,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Assembly Biosciences (ASMB) said Monday the first participant has been dosed in the phase 1b portion",
      "url": "https://finnhub.io/api/news?id=2536659f2a5724962b4cc9da872bb6ce346b308b09ebce3d0618341b3fbeebeb"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc.(NasdaqGS: GILD) added to Russell 3000 Growth Index",
    "summary": "Gilead Sciences, Inc. added to Russell 3000 Growth Index...",
    "url": "https://finnhub.io/api/news?id=2ef49dbf526c8f36e87af3ff1b523ac826f2619e66dd901da93404ff8ea04f90",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751291220,
      "headline": "Gilead Sciences, Inc.(NasdaqGS: GILD) added to Russell 3000 Growth Index",
      "id": 135664854,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Gilead Sciences, Inc. added to Russell 3000 Growth Index...",
      "url": "https://finnhub.io/api/news?id=2ef49dbf526c8f36e87af3ff1b523ac826f2619e66dd901da93404ff8ea04f90"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc.(NasdaqGS: GILD) added to Russell 1000 Growth-Defensive Index",
    "summary": "Gilead Sciences, Inc. added to Russell 1000 Growth-Defensive Index...",
    "url": "https://finnhub.io/api/news?id=245fcd2b5cc2ada86feb2f730a4b03c9ec64cecc348dfde5c714cc09bc01c480",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751288176,
      "headline": "Gilead Sciences, Inc.(NasdaqGS: GILD) added to Russell 1000 Growth-Defensive Index",
      "id": 135660662,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Gilead Sciences, Inc. added to Russell 1000 Growth-Defensive Index...",
      "url": "https://finnhub.io/api/news?id=245fcd2b5cc2ada86feb2f730a4b03c9ec64cecc348dfde5c714cc09bc01c480"
    }
  },
  {
    "ts": null,
    "headline": "Gilead extends gains after Supreme Court upheld an Obamacare provision",
    "summary": "Investing.com -- The U.S. Supreme Court upheld a provision of the Affordable Care Act requiring insurers to cover preventive services, such as HIV prevention and cancer screenings, at no additional cost to patients.",
    "url": "https://finnhub.io/api/news?id=cb336fd143c6d9313f28d0e9a1862cd0118546d3623fdece50fca466c43c87fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751284536,
      "headline": "Gilead extends gains after Supreme Court upheld an Obamacare provision",
      "id": 135652722,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Investing.com -- The U.S. Supreme Court upheld a provision of the Affordable Care Act requiring insurers to cover preventive services, such as HIV prevention and cancer screenings, at no additional cost to patients.",
      "url": "https://finnhub.io/api/news?id=cb336fd143c6d9313f28d0e9a1862cd0118546d3623fdece50fca466c43c87fe"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc.(NasdaqGS: GILD) added to Russell 1000 Growth Index",
    "summary": "Gilead Sciences, Inc. added to Russell 1000 Growth Index...",
    "url": "https://finnhub.io/api/news?id=29cef1072821a1e8f723a0ccc441e34924af0668015d9db5d6d41daebea2737c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751274469,
      "headline": "Gilead Sciences, Inc.(NasdaqGS: GILD) added to Russell 1000 Growth Index",
      "id": 135651878,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Gilead Sciences, Inc. added to Russell 1000 Growth Index...",
      "url": "https://finnhub.io/api/news?id=29cef1072821a1e8f723a0ccc441e34924af0668015d9db5d6d41daebea2737c"
    }
  },
  {
    "ts": null,
    "headline": "This firm represents one of investing’s toughest moral debates",
    "summary": "While many big drug companies do amazing things for humanity, they’re also often vilified for profiteering from their work. This month, New York-listed Gilead Sciences has, not for the first time, reminded investors of the conundrum.",
    "url": "https://finnhub.io/api/news?id=0a6c66523e69612cbd49f11faa8c20c6d7512d771f76004491c42af062ed3e5f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751256000,
      "headline": "This firm represents one of investing’s toughest moral debates",
      "id": 135671766,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "While many big drug companies do amazing things for humanity, they’re also often vilified for profiteering from their work. This month, New York-listed Gilead Sciences has, not for the first time, reminded investors of the conundrum.",
      "url": "https://finnhub.io/api/news?id=0a6c66523e69612cbd49f11faa8c20c6d7512d771f76004491c42af062ed3e5f"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc.(NasdaqGS: GILD) added to Russell 3000E Growth Index",
    "summary": "Gilead Sciences, Inc. added to Russell 3000E Growth Index...",
    "url": "https://finnhub.io/api/news?id=562a7582e087154686b475693d77deb47eb6f89c0e929af8204cc731ca6eca14",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751255852,
      "headline": "Gilead Sciences, Inc.(NasdaqGS: GILD) added to Russell 3000E Growth Index",
      "id": 135643778,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Gilead Sciences, Inc. added to Russell 3000E Growth Index...",
      "url": "https://finnhub.io/api/news?id=562a7582e087154686b475693d77deb47eb6f89c0e929af8204cc731ca6eca14"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc.(NasdaqGS: GILD) added to Russell Top 200 Growth Index",
    "summary": "Gilead Sciences, Inc. added to Russell Top 200 Growth Index...",
    "url": "https://finnhub.io/api/news?id=7007de43a8f36842bf7a074e059e1bb2e7db95137225e1d445ea8e7ae90e7707",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751254882,
      "headline": "Gilead Sciences, Inc.(NasdaqGS: GILD) added to Russell Top 200 Growth Index",
      "id": 135643195,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Gilead Sciences, Inc. added to Russell Top 200 Growth Index...",
      "url": "https://finnhub.io/api/news?id=7007de43a8f36842bf7a074e059e1bb2e7db95137225e1d445ea8e7ae90e7707"
    }
  }
]